ARTICLE | Company News
Ludwig Institute, CRI, Targovax deal
November 23, 2015 8:00 AM UTC
The institutes partnered with Targovax to evaluate ONCOS-102 in combination with undisclosed compounds, including checkpoint inhibitors, in Phase I and/or Phase IIa trials to treat several cancer typ...